Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Most nonemergent diagnoses can’t be predicted
MDedge Endocrinology
Hypertension and CVD risk for young adults
MDedge Endocrinology
Biomarkers and concussions
MDedge Endocrinology
Samuel Shem: Part II
MDedge Endocrinology
Trump rule and ACA contraception
MDedge Endocrinology
Heart failure and sacubiril/valsartan
MDedge Endocrinology
Vitamin D, fish out, and primary prevention
MDedge Endocrinology
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Endocrinology
Obesity curbs decades of CVD progress
MDedge Endocrinology
Physical fitness guidelines from HHS
MDedge Endocrinology